Global healthcare is a $12 trillion market carrying a 34-million worker shortage, yet healthtech captured just 5% of the $712 billion in global venture capital deployed in the first half of 2026. That gap, a trillion-dollar industry still treated as a rounding error by the venture industry, is the starting point for everything else here. We at Verge HealthTech Fund have always talked about how healthcare should transform from “sick-care” to “health + care.”

Direct macro intelligence synthesized from main-stage keynotes and private allocator dialogues at the seventh Longevity Investors Conference in Gstaad. What Top Allocators at the Longevity Investors Conference Are Quietly Rotating Out Of—and the Sovereign Infrastructure Replacing It.

Capital follows vitality. Here is where the global longevity, investment, and high-performance ecosystem meets next.

When most executives track performance, it’s on spreadsheets: revenue growth, market share, ROI. But the single most critical metric for executive health and longevity may not appear on any balance sheet—it’s in your lungs, heart, and mitochondria. That metric is VO₂max, the maximal oxygen your body can consume during peak exertion. For high-performing leaders, VO₂max has quietly become the ultimate measure of resilience, vitality, and long-term cognitive and operational capa

Switzerland hasn't just become a family office fortress; it has become the global headquarters for the "Biological Balance Sheet." The headlines suggest that Swiss banking secrecy ended in 2018. The reality? Capital is flooding in faster than ever. But a more profound shift is occurring beneath the surface. Families are no longer establishing $4B+ single-family offices (SFOs) merely to manage portfolios. They are anchoring themselves in Switzerland to manage the most criti